Enhanced lymph vessel density, remodeling, and inflammation are reflected by gene expression signatures in dermal lymphatic endothelial cells in type 2 diabetes

Diabetes

Volumn 62, Issue 7, 2013, Pages 2509-2529

  Haemmerle, Monika ^a   Keller, Thomas ^a   Egger, Gerda ^a   Schachner, Helga ^a   Steiner, Carl Walter ^a   Stokic, Dejan ^a   Neumayer, Christoph ^a   Brown, Markus K ^a   Kerjaschki, Dontscho ^a   Hantusch, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIPID; TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTOME;

ARTICLE; BIOINFORMATICS; CELL ADHESION; CELL DENSITY; CELL MOTILITY; CONTROLLED STUDY; DERMAL LYMPHATIC ENDOTHELIAL CELL; DERMATITIS; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID TRANSPORT; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN INFECTION; SKIN MANIFESTATION; SKIN ULCER; UPREGULATION; WOUND HEALING IMPAIRMENT; ADULT; DERMIS; GENE EXPRESSION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY;

ADULT; CHEMOKINE CXCL10; DERMIS; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INFLAMMATION; LYMPHATIC VESSELS; MACROPHAGES; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883698439     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0844     Document Type: Article

References (51)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053
2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-1346
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801
4. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009;462:307-314
5. Hermans MP. Diabetes and the endothelium. Acta Clin Belg 2007;62:97- 101
6. Van Hattem S, Bootsma AH, Thio HB. Skin manifestations of diabetes. Cleve Clin J Med 2008;75:772, 774, 776-777 passim
7. Jansson P-A. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 2007;262:173-183
8. Wang Y, Oliver G. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 2010;24:2115-2126
9. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011;17:1371-1380
10. Wick N, Saharinen P, Saharinen J, et al. Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics 2007;28:179-192
11. Stokic D, Wick N, Biely C, Gurnhofer E, Thurner S. Statistically consistent identification of differentially expressed genes in DNA chip data over the whole expression range: relative variance method. Appl Bioinformatics 2006;5:277-284
12. Wiggins H, Rappoport J. An agarose spot assay for chemotactic invasion. Biotechniques 2010;48:121-124
13. Middleton J, Americh L, Gayon R, et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005;206:260-268
14. Wick N, Haluza D, Gurnhofer E, et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol 2008;173:1202-1209
15. Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A 2002;99:16069-16074
16. Khanna S, Biswas S, Shang Y, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 2010;5: e9539
17. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
18. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005;115:2316-2319
19. Kainulainen V, Nelimarkka L, Järveläinen H, Laato M, Jalkanen M, Elenius K. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J Biol Chem 1996;271:18759-18766
20. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006;203:2763-2777
21. Leu S-J, Lam SC-T, Lau LF. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 2002;277:46248-46255
22. Mirza M, Pang MF, Zaini MA, et al. Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in mice. PLoS ONE 2012;7:e37523
23. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFNgamma- inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002;168: 3195-3204
24. Moriguchi P, Sannomiya P, Lara PF, Oliveira-Filho RM, Greco KV, Sudo- Hayashi LS. Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia. Diabetes Metab Res Rev 2005;21:150-157
25. Kivelä R, Silvennoinen M, Lehti M, Kainulainen H, Vihko V. Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle. Am J Physiol Heart Circ Physiol 2007;293:H2573-H2579
26. Plum L, Wunderlich FT, Baudler S, Krone W, Brüning JC. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology (Bethesda) 2005;20:152-161
27. Kaufmann A, Molnár B, Craciun C, Itcus A. Diabetic lymphangiopathy. An optical and electron microscopic study. Lymphology 1980;13:202- 206
28. Kholová I, Dragneva G, Cermáková P, et al. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterolrich and calcified atherosclerotic lesions. Eur J Clin Invest 2011;41:487-497
29. Fernandez AP, Mitiva M, Roberts B, Ricotti C, Rouhani P, Romanelli P. Histopathologic analysis of dermal lymphatic alterations in chronic venous insufficiency ulcers using D2-40. J Am Acad Dermatol 2011;64:1123.e1-12
30. Vainionpää N, Bützow R, Hukkanen M, et al. Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas. Cell Tissue Res 2007;328:317-328
31. Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 2008;27:3145-3155
32. Nguyen PD, Tutela JP, Thanik VD, et al. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Repair Regen 2010;18:553-559
33. Pirola L, Balcerczyk A, Tothill RW, et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 2011;21:1601-1615
34. Cayrol C, Lacroix C, Mathe C, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 2007;109:584-594
35. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817
36. Horra A, Salazar J, Ferré R, et al. Prox-1 and FOXC2 gene expression in adipose tissue: a potential contributory role of the lymphatic system to familial combined hyperlipidaemia. Atherosclerosis 2009;206:343-345
37. Vigl B, Aebischer D, Nitschké M, et al. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 2011;118:205-215
38. Harvey NL, Srinivasan RS, Dillard ME, et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Not as tenants in common Genet 2005;37:1072-1081
39. Irigoyen M, Ansó E, Martínez E, Garayoa M, Martínez-Irujo JJ, Rouzaut A. Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 2007;1773: 880-890
40. Ogunbiyi S, Chinien G, Field D, et al London Lymphedema Consortium. Molecular characterization of dermal lymphatic endothelial cells from primary lymphedema skin. Lymphat Res Biol 2011;9:19-30
41. Charles CA, Tomic-Canic M, Vincek V, et al. A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol 2008;59:758-771
42. Roy S, Khanna S, Rink C, Biswas S, Sen CK. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics 2008;34:162-184
43. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, Liechty KW, Segre JA; NISC Comparative Sequencing Program. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci U S A 2010;107:14799-14804
44. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology 2011; 216:753-762
45. Wetzler C, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000;115:245-253
46. Brandner JM, Zacheja S, Houdek P, Moll I, Lobmann R. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care 2008;31:114-120
47. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601
48. Baluk P, Yao LC, Feng J, et al. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 2009;119:2954-2964
49. Labanaris AP, Polykandriotis E, Horch RE. The effect of vacuum-assisted closure on lymph vessels in chronic wounds. J Plast Reconstr Aesthet Surg 2009;62:1068-1075
50. von der Weid PY, Rehal S, Ferraz JG. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr Opin Gastroenterol 2011;27:335-341
51. Kim KE, Koh YJ, Jeon BH, et al. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 2009;175:1733-1745